Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion

Journal of Neuroscience

Volumn 23, Issue 3, 2003, Pages 1006-1012

  Narita, Minoru ^a   Mizuo, Keisuke ^a   Mizoguchi, Hirokazu ^b   Sakata, Mamoru ^a   Narita, Michiko ^a   Tseng, Leon F ^b   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Dopamine D3 receptor; Hyperlocomotion; Morphine; Negative feedback system; Rewarding effect

Indexed keywords

DOPAMINE 3 RECEPTOR; ENKEPHALIN; MORPHINE; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GENE DELETION; LOCOMOTION; MESENCEPHALON; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PLACE PREFERENCE; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR GENE; RECEPTOR UPREGULATION; REINFORCEMENT; REWARD;

EID: 0037322568     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-03-01006.2003     Document Type: Article

References (41)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93:1945-1949.
2. Baik JH, Picetti R, Saiardi A, Thiriet G, Dierich A, Depaulis A, Le Meur M, Borrelli E (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377:424-428.
3. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264:489-495.
4. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC (1991) Localization ofdopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564:203-219.
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254.
6. Caine SB, Koob GF (1993) Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260:1814-1816.
7. Civelli O, Bunzow JR, Grandy DK (1993) Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 33:81-307.
8. Daly SA, Waddington JL (1993) Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists. Neuropharmacology 32:509-510.
9. De Boer P, Enrico P, Wright J, Wise LD, Timmerman W, Moor E, Dijkstra D, Wikstrom HV, Westerink BH (1997) Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels. Brain Res 758:83-91.
10. Devoto P, Collu M, Muntoni AL, Pistis M, Serra G, Gessa GL, Diana M (1995) Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse 20:153-155.
11. 3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 20:8677-8684.
12. Funada M, Suzuki T, Misawa M (1994) The role of dopamine D1-receptors in morphine-induced hyperlocomotion in mice. Neurosci Lett 169:1-4.
13. 3 receptor in the presynaptic regulation of release but not synthesis. Eur J Pharmacol 308:261-269.
14. Gingrich JA, Caron MG (1993) Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 16:299-321.
15. Khroyan TV, Baker DA, Neisewander JL (1995) Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology 122:351-357.
16. 3 receptor mutant mice. J Neurosci 18:2231-2238.
17. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
18. Landwehrmeyer B, Mengod G, Palacios JM (1993) Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur J Neurosci 5:145-153.
19. Levant B (1997) The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49:231-252.
20. L'hirondel M, Cheramy A, Godeheu G, Artaud F, Saiardi A, Borrelli E, Glowinski J (1998) Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. Brain Res 792:253-262.
21. Maldonado R, Dauge V, Feger J, Roques BP (1990) Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats. Neuropharmacology 29:215-223.
22. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borrelli E (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388:586-589.
23. 3 receptors. Eur J Pharmacol 249:R5-R6.
24. Narita M, Suzuki T, Funada M, Misawa M,Nagase H (1993) Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by κ-opioid receptor activation in mice. Life Sci 52:397-404.
25. Narita M, Funada M, Suzuki T (2001) Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89:1-15.
26. Narita M, Mizuo K, Shibasaki M, Narita M, Suzuki T (2002a) Up-regulation of the G(q/11α) protein and protein kinase C during the development of sensitization to morphine-induced hyperlocomotion. Neuroscience 111:127-132.
27. 3 receptor. Neurosci Lett 324:129-132.
28. Phillips AG, LePiane FG, Fibiger HG (1983) Dopaminergic mediation of reward produced by direct injection of enkephalin into the ventral tegmental area of rat. Life Sci 33:2505-2511.
29. Richtand NM, Kelsoe JR, Segal DS, Kuczenski R (1995) Regional quantification of D1, D2, and D3 dopamine receptor mRNA in rat brain using a ribonuclease protection assay. Mol Brain Res 33:97-103.
30. Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, Fang Y, Larson JL, McDougall JA, Chester JA, Saez C, Pugsley TA, Gershanik O, Low MJ, Grandy DK (1997) Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90:991-1001.
31. Shippenberg TS, Herz A (1987) Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists. Brain Res 436:169-172.
32. Shippenberg TS, Herz A (1988) Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. Eur J Pharmacol 151:233-242.
33. Shippenberg TS, Bals-Kubik R, Herz A (1993) Examination of the neuro-chemical substrates mediating the motivational effects of opioid: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther 265:53-59.
34. Sokoloff P, Giros B, Martres M-P, Bouthnet M-L, Schwartz J-C (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146-151.
35. Stinus L, Winnock M, Kelley AE (1985) Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates. Psychopharmacology 85:323-328.
36. Stinus L, Nadaud D, Jauregui J, Kelley AE (1986) Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens. Biol Psychiatry 21:34-48.
37. Suzuki T, Masukawa Y, Misawa M (1990) Drug interactions in the reinforcing effects of over-the-counter cough syrups. Psychopharmacology 102:438-442.
38. Suzuki T, Maeda J, Funada M, Misawa M (1995) The D3-receptor agonist (+/-)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice. Neurosci Lett 187:45-48.
39. Waters N, Svensson K, Haadsma-Svensson SR, Smith MW, Carlsson A (1993) The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm Gen Sect 94:11-19.
40. Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191-225.
41. Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, White NM, Graybiel AM, White FJ, Tonegawa S (1997) Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19:837-848.